The latest price target for Cassava Sciences (NASDAQ:SAVA) was reported by HC Wainwright & Co. on November 8, 2024. The analyst firm set a price target for $116.00 expecting SAVA to rise to within 12 months (a possible 2750.55% upside). 9 analyst firms have reported ratings in the last year.

The latest analyst rating for Cassava Sciences (NASDAQ:SAVA) was provided by HC Wainwright & Co., and Cassava Sciences reiterated their buy rating.

The last upgrade for Cassava Sciences Inc happened on October 8, 2024 when HC Wainwright & Co. raised their price target to $116. HC Wainwright & Co. previously had a neutral for Cassava Sciences Inc.

The last downgrade for Cassava Sciences Inc happened on July 1, 2024 when Jones Trading changed their price target from N/A to N/A for Cassava Sciences Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cassava Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cassava Sciences was filed on November 8, 2024 so you should expect the next rating to be made available sometime around November 8, 2025.

While ratings are subjective and will change, the latest Cassava Sciences (SAVA) rating was a reiterated with a price target of $116.00 to $116.00. The current price Cassava Sciences (SAVA) is trading at is $4.07, which is out of the analyst’s predicted range.